On November 2nd 2009, Lonza acquired Algonomics.
Collaborations are a central component of our business strategy.
Celltrion to access Epibase IV for immunogenicity assessment of antibody biosimilars
Meet Lonza Gent (Algonomics) at Bio-Europe Spring
Barcelona, SP
Lonza Gent (Algonomics) will present on Visiongain's inaugural "Immunogenicity 2010"
London, UK
Meet Lonza Gent (Algonomics) at the Bio Convention
Chicago, IL, USA